Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 90 days matching "brain inflammation"

Clinical trialUNITERAREApr 3

New Recruiting Trial: A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)

Researchers are testing a new medicine called glycerol tributyrate to see if it can help people with two rare mitochondrial diseases: MELAS (a condition that causes brain inflammation, acid buildup in the blood, and stroke-like episodes) and LHON-Plus (a condition that damages the optic nerve and causes vision loss). This is an early-stage study that will enroll patients starting in April 2026.

WHY IT MATTERSThis is the first clinical trial testing glycerol tributyrate specifically in MELAS and LHON-Plus patients, offering a potential new treatment option for these currently untreatable mitochondrial disorders.
→ You can act on thisMitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)Read →
ResearchPUBMEDMar 26

Unilateral Primary Angiitis of the Central Nervous System: A Rare and Under-Recognized Entity.

Doctors have identified a rare form of brain inflammation called unilateral primary angiitis of the central nervous system (U-PACNS) that affects only one side of the brain instead of both sides. This condition is often missed or confused with other diseases like brain tumors or multiple sclerosis because it looks similar on imaging tests. The article explains how doctors can better recognize and diagnose this condition by understanding its unique features.

WHY IT MATTERSIf you've been diagnosed with a one-sided brain lesion or inflammation that doctors can't fully explain, this research helps clarify that U-PACNS should be considered in your differential diagnosis, potentially changing your treatment approach.
💬 Ask your doctorPrimary Angiitis of the Central Nervous System (PACNS)Unilateral Primary Angiitis of the Central Nervous System (U-PACNS)Read →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases